Specialties

Patients living with complex, hard-to-diagnose conditions often face a long and difficult journey. Many spend years seeing multiple specialists before receiving an accurate diagnosis, and managing treatment and its challenges can be an ongoing, day-to-day burden.

Supported Specialties

As a specialty pharmacy dedicated to supporting patients with complex conditions, we are committed to guiding you through every stage of your treatment journey—both clinically and administratively—to help you achieve the best possible outcomes. Our Therapy Care Teams are highly trained in each condition we support, enabling us to deliver personalized care tailored to the unique needs of every patient. Learn more about the conditions we support below.

  • Oncology

    Oncology is the study and treatment of cancers, a large group of diseases of abnormal cell growth. Cancer is the second leading cause of death in the US.
    Learn More about Oncology

  • Osteoporosis

    Osteoporosis is a disease of weakening bones. If not treated, bone continues to break down, and the risk of breaking a bone in a fall continues to go up.
    Learn More about Osteoporosis

  • Pulmonary Hypertension

    Pulmonary hypertension is a rare disease where blood vessels in the lungs become stiff and narrow. Treatment focuses on making it easier to breathe.
    Learn More about Pulmonary Hypertension

  • Sickle Cell Disease

    Sickle cell disease is an inherited disease that causes red blood cells to form a “sickle” shape. The sickled cells cannot carry as much oxygen and can get stuck in small blood vessels, causing severe pain.
    Learn More about Sickle Cell Disease

  • Transplant – Bone Marrow

    A bone marrow transplant is a procedure in which certain cells are taken from a person and either given to another person or treated and given back to the original person to cure a disease.
    Learn More about Transplant – Bone Marrow

  • Transplant – Solid Organ

    A solid organ transplant is a procedure in which a new organ is placed in the body to cure a disease. After a transplant, many medications are needed to keep the body from rejecting the new organ and to prevent certain diseases.
    Learn More about Transplant – Solid Organ

Therapy Solutions

Advanced therapies for certain conditions can be as complex as the diseases themselves. As a specialty pharmacy, we are trained and experienced in navigating the entire prescription process. We work with your prescriber to secure insurance approval, and we make sure you have access to all possible copay lowering solutions. From instruction on the use and storage of your new medication to streamlined refills, our team tailors care to you. Learn more about the therapies we support below.

  • Winrevair (sotatercept)

    Winrevair (sotatercept) is an injectable activin signaling inhibitor approved to increase exercise capacity and reduce the risk of decompensation in patients with certain types of pulmonary hypertension. In clinical study, Winrevair was added to baseline therapies for pulmonary hypertension.

  • Xeljanz (tofacitinib)

    Xeljanz (tofacitinib) is a Janus kinase inhibitor approved to reduce the inflammation in rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, ulcerative colitis, and polyarticular juvenile idiopathic arthritis.

  • Xphozah (tenapanor)

    Xphozah (tenapanor) inhibits an exchange protein in the lining of the colon and small intestine, preventing absorption of sodium and phosphate from the GI tract. Xphozah does not directly bind phosphate but is used in addition to (and occasionally in place of) direct phosphate binders.

  • Yesintek (ustekinumab-kfce)

    Yesintek (ustekinumab-kfce) is an FDA-approved biosimilar to Stelara. Like Stelara, Yesintek is a monoclonal antibody that blocks the action of interleukins 12 and 23 to reduce inflammation in psoriatic arthritis, Crohn’s disease, ulcerative colitis, and plaque psoriasis.

  • Yuflyma (adalimumab-aaty)

    Yuflyma (adalimumab-aaty) is an FDA-approved, citrate-free biosimilar to Humira. Like Humira, Yuflyma is a monoclonal antibody that blocks the action of TNF-alpha to reduce inflammation in rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and panuveitis.

  • Yusimry (adalimumab-aqvh)

    Yusimry (adalimumab-aqvh) is an FDA-approved biosimilar to Humira. Like Humira, Yusimry is a monoclonal antibody that blocks the action of TNF-alpha to reduce inflammation in rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, plaque psoriasis, hidradenitis suppurativa, and panuveitis.

  • Yutrepia (treprostinil)

    Yutrepia (treprostinil) is an inhaled dosage form of the prostacyclin mimic treprostinil given to patients with certain forms of pulmonary hypertension to increase exercise tolerance. Yutrepia is inhaled through a capsule-based inhaler.

  • Zenpep (pancrelipase)

    Zenpep (pancrelipase) is a pancreatic enzyme product that contains a mixture of lipases, proteases, and amylases. By mimicing the digestive enzymes naturally secreated by the pancreas, Zenpep aids in the digestion of fat from meals in patients who are unable to produce enough pancreatic enzymes.

  • Zepatier (elbasvir/grazoprevir)

    Zepatier (elbasvir/grazoprevir) is a combination of two antiviral medications approved to treat chronic hepatitis C infection in patients with hepatitis C genotype 1 or 4 and without cirrhosis or with compensated cirrhosis.
View All Drug Therapies

Stay Connected

Get the latest news and updates

Contact Us Now